{"id":7846,"date":"2011-04-21T12:19:26","date_gmt":"2011-04-21T16:19:26","guid":{"rendered":"http:\/\/1boringoldman.com\/?p=7846"},"modified":"2011-04-22T18:52:38","modified_gmt":"2011-04-22T22:52:38","slug":"personalized-medicine-a-preventive-medicine-polemic","status":"publish","type":"post","link":"https:\/\/1boringoldman.com\/index.php\/2011\/04\/21\/personalized-medicine-a-preventive-medicine-polemic\/","title":{"rendered":"personalized medicine: a preventive medicine polemic&#8230;"},"content":{"rendered":"<div align=\"justify\"><sup><em><font color=\"#999999\">Depression will be the second leading contributor to the burden of disease by 2020. There is therefore an urgent need to identify objective indicators of risk for depression, and to understand their link to underlying biological mechanisms and treatment. To date, candidate risk markers such as genetic polymorphisms, vulnerability to stress, personality traits, and alterations in brain function, structure and cognition have tended to be assessed in separate studies. The integrative relationships between these factors, and how they may interact to predict depression and anxiety, remain unknown&#8230;<\/font><\/em><\/sup><sub><a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed?term=Interactions%20between%20BDNF%20Val66Met%20polymorphism%20and%20early%20life%20stress%20predict%20brain%20and%20arousal%20pathways%20to%20syndromal%20depression%20and%20anxiety\" target=\"_blank\"><strong>ref<\/strong><\/a><\/sub><\/div>\n<p align=\"justify\">In my last post, I talked about some of the emergent paradigms in the modern medical scene &#8211; <strong><font color=\"#200020\">evidence-based medicine<\/font><\/strong>, <strong><font color=\"#200020\">translational medicine<\/font><\/strong>, and <strong><font color=\"#200020\">personalized medicine<\/font><\/strong>. It was kind of boring, but I don&#8217;t know what I think until I say some things, then I figure out what I wanted to say but hadn&#8217;t quite formulated. What I really wanted to talk about was a much older medical paradigm that trumps these new pretenders to the throne &#8211; <strong><font color=\"#200020\">preventive medicine<\/font><\/strong>.<\/p>\n<p align=\"justify\">Descriptions of the development of medicine usually go like this: Doctors began by focusing on treating the illnesses that were solidly in place, trying to relieve suffering and prevent deterioration [now called <strong><em>tertiary prevention<\/em><\/strong>]. Then they figured out that if you could get there before the disease was firmly entrenched, you had a better shot [so Crawford Long took out the appendix before it ruptured, women get mammograms to find the earliest sign of breast cancer][now called early detection &#8211; <strong><em>secondary prevention<\/em><\/strong>]. Then doctors figured out an even better idea. If possible, prevent the disease altogether [don&#8217;t smoke, don&#8217;t use asbestos, get immunizations, kill mosquitoes, etc][that&#8217;s called <strong><em>primary prevention<\/em><\/strong>].<\/p>\n<p align=\"justify\">But that story leaves out the oldest medical principle of all,<strong><font color=\"#400040\"> <em>primum non nocere<\/em><\/font><\/strong> [first, do no harm]. It&#8217;s paradoxically called <strong><em>quaternary prevention<\/em><\/strong> &#8211; which seems odd. Shouldn&#8217;t it come first? Whatever. Here&#8217;s the official lexicon for preventive medicine:            <\/p>\n<table width=\"95%\" cellspacing=\"0\" cellpadding=\"2\" border=\"0\" align=\"center\">\n<tr>\n<td align=\"center\" colspan=\"2\"><strong><font color=\"#200020\">PREVENTIVE MEDICINE<\/font><\/strong><\/p>\n<hr size=\"1\" \/><\/td>\n<\/tr>\n<tr>\n<td align=\"center\"><strong>Level<\/strong><\/td>\n<td align=\"center\"><strong>Definition<\/strong><\/td>\n<\/tr>\n<tr>\n<td valign=\"top\">Primary prevention<\/td>\n<td align=\"justify\">Primary prevention strategies intend to avoid the development of disease. Most population-based health promotion activities are primary preventive measures.<\/td>\n<\/tr>\n<tr>\n<td valign=\"top\">Secondary prevention<\/td>\n<td align=\"justify\">Secondary prevention strategies attempt to diagnose and treat an existing disease in its early stages before it results in significant morbidity.<\/td>\n<\/tr>\n<tr>\n<td valign=\"top\">Tertiary prevention<\/td>\n<td align=\"justify\">These treatments aim to reduce the negative impact of established disease by restoring function and reducing disease-related complications.<\/td>\n<\/tr>\n<tr>\n<td width=\"130\" valign=\"top\">Quaternary prevention<\/td>\n<td align=\"justify\"><strong><font color=\"#300030\">This term describes the set of health activities that mitigate or avoid the consequences of unnecessary or excessive interventions in the health system.<\/font><\/strong><\/td>\n<\/tr>\n<\/table>\n<p>          <\/p>\n<div align=\"justify\">When I read the psychiatric literature about personalized medicine, I find two themes:<\/div>\n<ul>\n<li>\n<div align=\"justify\">We need to find biomarkers to <u>anticipate<\/u> the development of illness.<\/div>\n<\/li>\n<li>\n<div align=\"justify\">We need to find biomarkers that will <u>direct our treatment<\/u> of illness.<\/div>\n<\/li>\n<\/ul>\n<div align=\"justify\">Right now, I&#8217;m focusing on the first theme. These days, when I read articles that start with lines like this, I&#8217;m finding myself wincing:<\/div>\n<ul>\n<div align=\"justify\"><em><font color=\"#999999\">Depression will be the second leading  contributor to the burden of disease by 2020. There is therefore an  urgent need to identify objective indicators of risk for depression&#8230;<\/font><\/em><\/div>\n<\/ul>\n<div align=\"justify\">In the paper, it comes with a <a target=\"_blank\" href=\"http:\/\/www.who.int\/mental_health\/management\/depression\/definition\/en\/\"><u><strong><font color=\"#200020\">link<\/font><\/strong><\/u><\/a> to the world health organization&#8217;s web-site. I see the phrase &quot;&#8230;there is an urgent need&#8230;&quot; as a disingenuous trick. Lots of scientific articles start with something about why this particular study is just about the most important thing on the scientific horizon. That&#8217;s benign narcissism. But this &quot;urgent need&quot; stuff is more than that. It means &quot;we need to screen people for objective indicators of their coming depression so we can&#8230;&quot; So we can what? Scare them? Not hire them? Of course not. They mean, &quot;So we can treat them thereby preventing the burden of disease.&quot; Problem is, we don&#8217;t have such a treatment available. If we had a biomarker for coming depression, what we ought to do is find some scientist who has an idea about what that biomarker might mean and give him\/her a NIMH grant to study incipient depression. But what Dr. Charles Nemeroff who is an author on that paper up there means is probably to give more antidepressant medications. That&#8217;s what he usually means. And what Dr. Evian Gordon, another author [and CEO of <strong><font color=\"#660033\">Brain Resource]<\/font><\/strong>, probably means is to use <strong><font color=\"#660033\">Brain Resource<\/font><\/strong>&#8216;s tools to screen people. Those are speculations, but they&#8217;re not bad guesses because the &quot;urgency&quot; is otherwise unexplainable.         <\/div>\n<p align=\"justify\">Whether my suspicions that <strong><font color=\"#200020\">personalized medicine<\/font><\/strong> is being coopted in psychiatry by the same people that embraced every psychopharmacologic intervention introduced by their own corporate sponsors is really immaterial. What&#8217;s cogent is that they are evoking <strong><font color=\"#200020\">preventive medicine<\/font><\/strong> principles prematurely [<em>primary<\/em> and <em>secondary<\/em> prevention]. We are, at best, struggling with <em>tertiary<\/em> prevention with the use of medications in depression. The medications &quot;reduce the negative impact of established disease by restoring function and reducing disease-related complications&quot; in only a percentage of patients, a smaller percentage than we&#8217;d like. And they are ignoring the growing body of evidence that we should be thinking more carefully about <em>quaternary<\/em> prevention [&#8230; activities that mitigate or avoid the consequences of unnecessary or excessive interventions in the health system]. Many recent books [<strong>The Anatomy of an Epidemic<\/strong>, <strong>Side Effects<\/strong>, <strong>Let Them Eat Prozac<\/strong>, etc etc] make it very clear that, if anything, we&#8217;re treating way too many people &#8211; not vice versa &#8211; and particularly with antidepressants.        <\/p>\n<p align=\"justify\">In spite of worrying about living up to my 1boringoldman moniker, I&#8217;m lingering here talking about paradigms for a reason. It&#8217;s very easy to go after the profit motives of the pharmaceutical companies, the kols like Nemeroff whose track record invalidate their scientific prowess, or the best laid plans of the likes of <strong><font color=\"#660033\">Brain Resource<\/font><\/strong>. But attacks on profit motives aren&#8217;t really fair. That&#8217;s a human thing, underpinning almost any business enterprise. And though I expect I&#8217;ll make those assaults on the wave of <strong><font color=\"#200020\">personalized medicine <\/font><\/strong>that&#8217;s moving to psychiatry&#8217;s front burner shortly, right now I want to hang around in paradigm-land for a while because I think that&#8217;s where our real focus should be centered.<\/p>\n<p align=\"justify\">The down-side of <strong><font color=\"#200020\">evidence-based medicine<\/font><\/strong> has been that we&#8217;ve accepted corporate sponsored clinical trials from a questionable Clinical Trials Industry that showed statistical but underwhelming <strong><font color=\"#200020\">evidence<\/font><\/strong> of efficacy and allowed the drugs to be used as if they were digital [depression = antidepressant], which they aren&#8217;t. The down-side of <strong><font color=\"#200020\">translational medicine<\/font><\/strong> is that we&#8217;ve raced to market with some shaky medications and been caught up in a whirlwind of worry about new medications in the pipeline at the expense of being careful, or even honest, about the drugs being prescribed. Now we have <strong><font color=\"#200020\">personalized medicine<\/font><\/strong>. Biomarkers of depression may be of scientific interest, but there&#8217;s no &quot;urgency&quot; for patient care until we have a reason to measure them. Trolling for patients is not a <strong><font color=\"#200020\">preventive medicine<\/font><\/strong> principle. Likewise, the excitement about <strong><font color=\"#200020\">personalized medicine<\/font><\/strong> leading us to decide which antidepressant to use is the lucrative fantasy of people who do screening for a living. A more rational approach would be to find a biomarker to see <strong><font color=\"#200020\">if<\/font><\/strong> an antidepressant is even indicated at all, rather than <strong><font color=\"#200020\">which one<\/font><\/strong>. That would be a better fit for the state of the art than what our <strong><font color=\"#200020\">personalized medicine<\/font><\/strong> gurus have in mind.<\/p>\n<div align=\"justify\">Just one more polemic before moving on. The head of the NIMH, the earnest Dr. Tom Insel, has been a champion for <strong><font color=\"#200020\">evidence-based medicine<\/font><\/strong>, <strong><font color=\"#200020\">translational medicine<\/font><\/strong>, and now <strong><font color=\"#200020\">personalized medicine<\/font><\/strong>. Even more, he&#8217;s quick to create Psychiatry in his own image, exemplified by his now famous article, <a target=\"_blank\" href=\"http:\/\/www.medicine.mcgill.ca\/oslerweb\/InselQuirion2005.pdf\"><strong><font color=\"#200020\">Psychiatry as a Clinical Neuroscience Discipline<\/font><\/strong><\/a>, in 2005. I don&#8217;t question that he is a neuroscientist, or that neuroscience is a very important scientific discipline, but I would like to remind him that psychiatrists are defined by the illnesses they treat and the patients who seek them out, not by their scientific interests or their attachment to the medical paradigm du jour. I expect that is a criticism Insel himself made of the psychoanalysts and existentialists of an earlier era. Insel and his friends whose names fill this and many other blogs are the worst kind of scientists of all. They think they know where things are headed and are in an &quot;urgent&quot; hurry to get us there. Real scientists don&#8217;t know such things. They sail on the winds of observation and experiment, not those of the borrowed paradigms of the hour&#8230;     <\/div>\n","protected":false},"excerpt":{"rendered":"<p>Depression will be the second leading contributor to the burden of disease by 2020. There is therefore an urgent need to identify objective indicators of risk for depression, and to understand their link to underlying biological mechanisms and treatment. To date, candidate risk markers such as genetic polymorphisms, vulnerability to stress, personality traits, and alterations [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_forum_subforum_count":0,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-7846","post","type-post","status-publish","format-standard","hentry","category-politics"],"_links":{"self":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/7846","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/comments?post=7846"}],"version-history":[{"count":38,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/7846\/revisions"}],"predecessor-version":[{"id":7914,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/7846\/revisions\/7914"}],"wp:attachment":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/media?parent=7846"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/categories?post=7846"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/tags?post=7846"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}